Brief: Medivir: Renegotiated Agreement With Tetralogic Regarding Birinapant

Medivir AB

11/12/2020 07:42

Dec 11 (Reuters) - Medivir AB  MVIRb.ST :
    * MEDIVIR STRENGTHENS ITS BUSINESS DEVELOPMENT POSSIBILITIES
THROUGH A RENEGOTIATED AGREEMENT WITH TETRALOGIC REGARDING
BIRINAPANT
    * THE PURPOSE OF NEW AGREEMENT IS TO CREATE IMPROVED
BUSINESS
DEVELOPMENT OPPORTUNITIES.
    * ORIGINAL AGREEMENT HAS BEEN DISSOLVED AND RENEGOTIATED SO
THAT
COMPENSATION MEDIVIR IS OBLIGED TO PAY IN A POTENTIAL FUTURE
TRANSACTION IS NOW BASED SOLELY ON DISTRIBUTION OF ACTUAL FUTURE
REVENUES TO MEDIVIR.

Source text: https://bit.ly/3gFtUXd
Further company coverage:  MVIRb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))